TrialThe Journal of infectious diseases2009

Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older.

Ann R Falsey et al.PubMed ↗Publisher ↗

No numbers read from the abstract.